Uterine Carcinosarcomas (Malignant Mixed Müllerian Tumours): A Review with Special Emphasis on the Controversies in Management
Open Access
- 5 October 2011
- journal article
- review article
- Published by Hindawi Limited in Obstetrics and Gynecology International
- Vol. 2011, 1-13
- https://doi.org/10.1155/2011/470795
Abstract
Uterine carcinosarcomas (MMMT—malignant mixed Müllerian tumours) are highly aggressive, rare, biphasic tumours composed of epithelial and mesenchymal elements believed to arise from a monoclonal origin. While hysterectomy with bilateral salpingo-oophorectomy remains the mainstay treatment, high rates of recurrence and metastases suggest a need for lymphadenectomy and postoperative adjuvant treatment. There are no established consensus guidelines for therapeutic patient management. Though well recognized that it improves locoregional control, the role of radiation in improving overall survival outcomes remains undecided. Although various combinations of chemotherapy have been explored, an optimal therapeutic modality is yet to be determined. As overall survival rates have not improved in thirty years, it is suggested that targeted chemotherapy and/or a multimodality approach may yield better outcomes. This paper provides a summary of the aetiopathogenesis of carcinosarcomas (MMMT) limited to the uterus with special emphasis on the controversies in the management of these patients.Keywords
This publication has 74 references indexed in Scilit:
- Uterine CarcinosarcomaClinical Obstetrics and Gynecology, 2011
- MRI Appearances of Uterine Malignant Mixed Müllerian TumorsAmerican Journal of Roentgenology, 2010
- Carboplatin plus paclitaxel for advanced or recurrent uterine malignant mixed mullerian tumors. The British Columbia Cancer Agency experienceGynecologic Oncology, 2008
- Serum CA125 predicts extrauterine disease and survival in uterine carcinosarcomaGynecologic Oncology, 2007
- Prognostic Features of Surgical Stage I Uterine CarcinosarcomaThe American Journal of Surgical Pathology, 2007
- Phase III Trial of Ifosfamide With or Without Paclitaxel in Advanced Uterine Carcinosarcoma: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2007
- Malignant mixed mullerian tumor (MMMT) of the cervixGynecologic Oncology, 2005
- Carcinosarcomas (Malignant Mullerian Mixed Tumors) of the Uterus and Ovary: A Genetic Study With Special Reference to HistogenesisInternational Journal of Gynecological Pathology, 2003
- Positron Emission Tomography with 18F-Fluorodeoxyglucose of Uterine Sarcoma: A Comparison with Magnetic Resonance Imaging and Power Doppler ImagingGynecologic Oncology, 2001
- Patterns of metastasis in uterine sarcoma. An autopsy studyCancer, 1989